Improving pregnancy outcome for IVF patients with preimplantation genetic screening

Improving pregnancy outcome for IVF patients with preimplantation genetic screening is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1586/17474108.3.5.635

P2093author name stringSantiago Munné
P2860cites workPregnancy and delivery of healthy infants developed from vitrified oocytes in a stimulated in vitro fertilization-embryo transfer programQ48886538
Pregnancies following pre-conception diagnosis of common aneuploidies by fluorescent in-situ hybridizationQ49047326
Oocyte karyotyping by comparative genomic hybridization [correction of hybrydization] provides a highly reliable method for selecting "competent" embryos, markedly improving in vitro fertilization outcome: a multiphase study.Q50639751
Multiple micromanipulations for preimplantation genetic diagnosis do not affect embryo development to the blastocyst stage.Q50649629
Wide range of chromosome abnormalities in the embryos of young egg donors.Q50651270
The beneficial effects of preimplantation genetic diagnosis for aneuploidy support extensive clinical application.Q50661217
Influence of maternal age on the outcome of PGD for aneuploidy screening in patients with recurrent implantation failure.Q50661225
Efficacy and clinical outcome of preimplantation genetic diagnosis using FISH for couples of reciprocal and Robertsonian translocations: the Korean experience.Q50672374
Reliability of comparative genomic hybridization to detect chromosome abnormalities in first polar bodies and metaphase II oocytes.Q50672829
Multicolour FISH detects frequent chromosomal mosaicism and chaotic division in normal preimplantation embryos from fertile patients.Q50951072
Diagnostic efficiency, embryonic development and clinical outcome after the biopsy of one or two blastomeres for preimplantation genetic diagnosis.Q51968796
Cleavage anomalies in early human embryos and survival after prolonged culture in-vitro.Q52144237
Paternal age and maternal age are risk factors for miscarriage; results of a multicentre European study.Q52940098
Maternal age, morphology, development and chromosome abnormalities in over 6000 cleavage-stage embryos.Q53552393
Embryo morphology and development are dependent on the chromosomal complement.Q53586766
Guidelines for good practice in PGD: programme requirements and laboratory quality assurance.Q54714247
The combination of polar body and embryo biopsy does not affect embryo viabilityQ57001976
Double locus analysis of chromosome 21 for preimplantation genetic diagnosis of aneuploidyQ57006868
Increased efficiency of preimplantation genetic diagnosis for infertility using “no result rescue”Q57779224
Removal of 2 cells from cleavage stage embryos is likely to reduce the efficacy of chromosomal tests that are used to enhance implantation ratesQ57779232
Substandard application of preimplantation genetic screening may interfere with its clinical successQ57779238
Preimplantation genetic diagnosis for translocationsQ57779244
Preimplantation genetic diagnosis significantly reduces pregnancy loss in infertile couples: a multicenter studyQ57779247
PGD analysis for aneuploidy in a patient heterozygous for a polymorphism of chromosome 16(16qh−)Q57779301
Preimplantation genetic diagnosis as both a therapeutic and diagnostic tool in assisted reproductive technologyQ57779321
Scoring criteria for preimplantation genetic diagnosis of numerical abnormalities for chromosomes X, Y, 13, 16, 18 and 21Q57779450
Treatment-related chromosome abnormalities in human embryosQ57779469
Comparative genomic hybridization for molecular cytogenetic analysis of solid tumorsQ29618818
Comparative genomic hybridization analysis of human oocytes and polar bodiesQ30815751
Comparison of the results of human embryo biopsy and outcome of PGD after zona drilling using acid Tyrode medium or a laserQ30976958
Comparison of effects of zona drilling by non-contact infrared laser or acid Tyrode's on the development of human biopsied embryos as revealed by blastomere viability, cytoskeletal analysis and molecular cytogeneticsQ33231802
Recent advances and future developments in PGD.Q33830561
Positive outcome after preimplantation diagnosis of aneuploidy in human embryos.Q33872742
Preimplantation diagnosis for aneuploidies in patients undergoing in vitro fertilization with a poor prognosis: identification of the categories for which it should be proposed.Q33880192
Outcome of preimplantation genetic diagnosis of translocationsQ33944569
Incidence and timing of pregnancy losses: relevance to evaluating safety of early prenatal diagnosisQ34203045
The use of first polar bodies for preimplantation diagnosis of aneuploidyQ34303308
Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial.Q34357019
Preimplantation genetic diagnosis reduces pregnancy loss in women aged 35 years and older with a history of recurrent miscarriages.Q34440975
Fluorescence in situ hybridization reanalysis of day-6 human blastocysts diagnosed with aneuploidy on day 3.Q34465927
Developmental ability of chromosomally abnormal human embryos to develop to the blastocyst stageQ34517295
Recurrent miscarriage: a defect in nature's quality control?Q34768976
Influence of past reproductive performance on risk of spontaneous abortionQ35715568
FISH preimplantation diagnosis of chromosome aneuploidy in recurrent pregnancy wastageQ36267639
Discordance among blastomeres renders preimplantation genetic diagnosis for aneuploidy ineffectiveQ36268960
Chromosome abnormalities and their relationship to morphology and development of human embryosQ36396448
Preimplantation genetic testing: a Practice Committee opinionQ36975085
Increased susceptibility to maternal aneuploidy demonstrated by comparative genomic hybridization analysis of human MII oocytes and first polar bodiesQ40276706
A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriageQ40791097
Survival rate of human oocytes and pregnancy outcome after vitrification using slush nitrogen in assisted reproductive technologiesQ41612743
Poor oocyte quality rather than implantation failure as a cause of age-related decline in female fertilityQ42614542
Nuclear transfer for full karyotyping and preimplantation diagnosis for translocationsQ44241542
Blastomere fixation techniques and risk of misdiagnosis for preimplantation genetic diagnosis of aneuploidyQ44412800
Towards a full karyotype screening of interphase cells: 'FISH and chip' technologyQ46087360
Increased Maternal Age and the Risk of Fetal DeathQ46361888
Cytoplasmic fragmentation in activated eggs occurs in the cytokinetic phase of the cell cycle, in lieu of normal cytokinesis, and in response to cytoskeletal disorderQ46465708
Aneuploidy in the miscarriages of infertile women and the potential benefit of preimplanation genetic diagnosisQ46616152
Differences in chromosome susceptibility to aneuploidy and survival to first trimesterQ47226926
Aneuploidy study of human oocytes first polar body comparative genomic hybridization and metaphase II fluorescence in situ hybridization analysis.Q48808126
High frequency of chromosomal abnormalities in embryos obtained from oocyte donation cyclesQ48822070
Chromosome abnormalities in 1255 cleavage-stage human embryosQ48827038
Day 3 and day 5 morphological predictors of embryo viabilityQ48829283
Chromosome mosaicism in cleavage-stage human embryos: evidence of a maternal age effectQ48829983
First clinical application of comparative genomic hybridization and polar body testing for preimplantation genetic diagnosis of aneuploidyQ48852165
Chromosomal abnormalities in the first and second polar body.Q48877812
P433issue5
P921main subjectpregnancy outcomeQ66057507
P304page(s)635-646
P577publication date2008-09-01
P1433published inExpert Review of Obstetrics and GynecologyQ15751854
P1476titleImproving pregnancy outcome for IVF patients with preimplantation genetic screening
P478volume3

Search more.